CEL-SCI Corp CVM:NYSE American

Geert R Kersten, Director and CEO, purchased 25,000 shares of Cel-Sci (CVM) on Jul 06, 2021, for $200,000. After the Form 4 filing with the SEC, Kersten indirectly controls 1,146,298 shares of the company, which has a market value of $9.17 million as of the prior-day closing price.

During the most recent 90-day period, previous to the date of this filing, there have been 6 insider transactions reported to the SEC for Cel-Sci. These transactions came from the activities of 6 separate insiders that resulted in a net disposition of 5,317 company shares. Relative to the preceding 90-day window of time, there were 4 transactions from 4 insiders and resulted in the net acquisition of 959 shares.

This level of insider transactions is below that of the peer group average in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Peer group activity averaged 62.3 transactions per company, with company insiders acquiring on average 36,792 shares.

SEC Story Link http://www.sec.gov/Archives/edgar/data/725363/000164698921000006/xslF345X03/primary_doc.xml